NX210c
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NX210c, covering 2024-12-13 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: ALS Phase II Study of NX210c [Phase 2]
2 regulatory and trial events tracked for NX210c, covering 2024-12-13 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: ALS Phase II Study of NX210c [Phase 2]